ProfileGDS5822 / ILMN_3149251
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 90% 79% 85% 91% 84% 86% 81% 87% 89% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1510.190
GSM1276600PDAC Late Ablation Control 2128.979
GSM1276601PDAC Late Ablation Control 3318.885
GSM1276602PDAC Late Ablation 1585.891
GSM1276603PDAC Late Ablation 2252.384
GSM1276604PDAC Late Ablation 3340.586
GSM1303940PDAC Late Ablation_anti-CTLA4 1143.281
GSM1303941PDAC Late Ablation_anti-CTLA4 242787
GSM1303942PDAC Late Ablation_anti-CTLA4 3554.789